BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 19351823)

  • 1. RelB enhances prostate cancer growth: implications for the role of the nuclear factor-kappaB alternative pathway in tumorigenicity.
    Xu Y; Josson S; Fang F; Oberley TD; St Clair DK; Wan XS; Sun Y; Bakthavatchalu V; Muthuswamy A; St Clair WH
    Cancer Res; 2009 Apr; 69(8):3267-71. PubMed ID: 19351823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [NF-κB subunits regulate maspin expression in prostate cancer cells in vitro].
    Ma L; Shen YY; Zhou P; Zhou J; Guo F
    Zhonghua Zhong Liu Za Zhi; 2012 Mar; 34(3):165-8. PubMed ID: 22780967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RelB-dependent differential radiosensitization effect of STI571 on prostate cancer cells.
    Xu Y; Fang F; Sun Y; St Clair DK; St Clair WH
    Mol Cancer Ther; 2010 Apr; 9(4):803-12. PubMed ID: 20371728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The NF-κB subunit RelB regulates the migration and invasion abilities and the radio-sensitivity of prostate cancer cells.
    Wang J; Yi S; Zhou J; Zhang Y; Guo F
    Int J Oncol; 2016 Jul; 49(1):381-92. PubMed ID: 27121503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear localisation of nuclear factor-kappaB transcription factors in prostate cancer: an immunohistochemical study.
    Lessard L; Bégin LR; Gleave ME; Mes-Masson AM; Saad F
    Br J Cancer; 2005 Oct; 93(9):1019-23. PubMed ID: 16205698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maspin expression is regulated by the non-canonical NF-κB subunit in androgen-insensitive prostate cancer cell lines.
    Guo F; Kang S; Zhou P; Guo L; Ma L; Hou J
    Mol Immunol; 2011 Oct; 49(1-2):8-17. PubMed ID: 21856005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockage of RelB expression by gene silencing enhances the radiosensitivity of androgen‑independent prostate cancer cells.
    Zhu HC; Qiu T; Dan C; Liu XH; Hu CH
    Mol Med Rep; 2015 Feb; 11(2):1167-73. PubMed ID: 25370388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential Cross-Talk between Alternative and Classical NF-κB Pathways in Prostate Cancer Tissues as Measured by a Multi-Staining Immunofluorescence Co-Localization Assay.
    Labouba I; Le Page C; Communal L; Kristessen T; You X; Péant B; Barrès V; Gannon PO; Mes-Masson AM; Saad F
    PLoS One; 2015; 10(7):e0131024. PubMed ID: 26186215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RelB sustains endocrine resistant malignancy: an insight of noncanonical NF-κB pathway into breast Cancer progression.
    Wang M; Zhang Y; Xu Z; Qian P; Sun W; Wang X; Jian Z; Xia T; Xu Y; Tang J
    Cell Commun Signal; 2020 Aug; 18(1):128. PubMed ID: 32807176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inverse relationship between PSA and IL-8 in prostate cancer: an insight into a NF-κB-mediated mechanism.
    Xu Y; Fang F; St Clair DK; St Clair WH
    PLoS One; 2012; 7(3):e32905. PubMed ID: 22403723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alternative NF-κB signaling promotes colorectal tumorigenesis through transcriptionally upregulating Bcl-3.
    Tao Y; Liu Z; Hou Y; Wang S; Liu S; Jiang Y; Tan D; Ge Q; Li C; Hu Y; Liu Z; Chen X; Wang Q; Wang M; Zhang X
    Oncogene; 2018 Nov; 37(44):5887-5900. PubMed ID: 29973688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune Differentiation Regulator p100 Tunes NF-κB Responses to TNF.
    Chatterjee B; Roy P; Sarkar UA; Zhao M; Ratra Y; Singh A; Chawla M; De S; Gomes J; Sen R; Basak S
    Front Immunol; 2019; 10():997. PubMed ID: 31134075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of constitutive and tumor necrosis factor alpha-induced nuclear factor (NF)-kappaB activation and induction of apoptosis by apigenin in human prostate carcinoma PC-3 cells: correlation with down-regulation of NF-kappaB-responsive genes.
    Shukla S; Gupta S
    Clin Cancer Res; 2004 May; 10(9):3169-78. PubMed ID: 15131058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pivotal role of the alternative NF-kappaB pathway in maintenance of basal bone homeostasis and osteoclastogenesis.
    Soysa NS; Alles N; Weih D; Lovas A; Mian AH; Shimokawa H; Yasuda H; Weih F; Jimi E; Ohya K; Aoki K
    J Bone Miner Res; 2010 Apr; 25(4):809-18. PubMed ID: 19839765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SN52, a novel nuclear factor-kappaB inhibitor, blocks nuclear import of RelB:p52 dimer and sensitizes prostate cancer cells to ionizing radiation.
    Xu Y; Fang F; St Clair DK; Sompol P; Josson S; St Clair WH
    Mol Cancer Ther; 2008 Aug; 7(8):2367-76. PubMed ID: 18723484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RelB/p52 NF-kappaB complexes rescue an early delay in mammary gland development in transgenic mice with targeted superrepressor IkappaB-alpha expression and promote carcinogenesis of the mammary gland.
    Demicco EG; Kavanagh KT; Romieu-Mourez R; Wang X; Shin SR; Landesman-Bollag E; Seldin DC; Sonenshein GE
    Mol Cell Biol; 2005 Nov; 25(22):10136-47. PubMed ID: 16260626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The NF-κB RelB protein is an oncogenic driver of mesenchymal glioma.
    Lee DW; Ramakrishnan D; Valenta J; Parney IF; Bayless KJ; Sitcheran R
    PLoS One; 2013; 8(2):e57489. PubMed ID: 23451236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RelB/NF-κB links cell cycle transition and apoptosis to endometrioid adenocarcinoma tumorigenesis.
    Ge QL; Liu SH; Ai ZH; Tao MF; Ma L; Wen SY; Dai M; Liu F; Liu HS; Jiang RZ; Xue ZW; Jiang YH; Sun XH; Hu YM; Zhao YX; Chen X; Tao Y; Zhu XL; Ding WJ; Yang BQ; Liu DD; Zhang XR; Teng YC
    Cell Death Dis; 2016 Oct; 7(10):e2402. PubMed ID: 27711077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Constitutive activation of nuclear factor kappaB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer.
    Zerbini LF; Wang Y; Cho JY; Libermann TA
    Cancer Res; 2003 May; 63(9):2206-15. PubMed ID: 12727841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive Evaluation of Nuclear Factor-κΒ Expression Patterns in Non-Small Cell Lung Cancer.
    Giopanou I; Lilis I; Papaleonidopoulos V; Marazioti A; Spella M; Vreka M; Papadaki H; Stathopoulos GT
    PLoS One; 2015; 10(7):e0132527. PubMed ID: 26147201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.